ArticleMultiple sclerosis journal - experimental, translational and clinical

Effect of ocrelizumab on rates of retinal atrophy in relapsing multiple sclerosis.

Brenna McCormack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.